In Bangladeshi diabetic patients, a higher hemoglobin A1C is linked to an elevated white blood cell count
Keywords:
Diabetes, Blood parameters, White blood cell (WBC), Glycated hemoglobin, HemoglobinAbstract
Background
Diabetes mellitus (DM) is associated with altered white blood cell (WBC) and glycated hemoglobin dysfunction.
Aim
In this study, we were aimed to compare the status of hemoglobin, glycated hemoglobin and WBC level between diabetic and non diabetic patient’s group.
Methods
This study was conducted in the medicine department of Women’s Medical College and Hospital, Sylhet, Bangladesh. The number of participants was 142. All the patients enrolled were informed verbally about the study and written consent was taken from each patient. Ethical permission was obtained from the institute. All of the tests were performed according to the procedure adopted in the hospital for routine uses. Among the participants, 71 (male 47, female 24) were diagnosed as type-2 diabetics (T2DM) and the other was non-diabetes (male 32 and female 39).
Results
During this study, diabetic patients showed increased hemoglobin (Hb) and WBC level in diabetic blood than non-diabetic one. It has been supported by the study that, HbA1c is remarkably greater than that of New Delhi metallo-β-lactamase 1 (NDM-1) patients. So, our assumptions could be concluded as; diabetes mellitus is an inflammatory condition itself, which may play role in increased HbA1c and WBC count.
Conclusion
Therefore, elevated WBC count is independently associated with worsening of glucose metabolism and HbA1c may ameliorate the chronic low-grade inflammation such as type-2 diabetics (T2DM).
References
Agardh E, Allebeck P, Hallqvist J, Moradi T, Anna S. Type 2 diabetes incidence and socio-economic position: A systematic re-view and meta-analysis. Int J Epidemiol. 2011; 40: 804-818. doi: 10.1093/ije/dyr029
American Diabetes Association. 6. Glycemic targets: Standards of medical care in diabetes-2021. Diabetes Care . 2021; 44(1): S73- S84. doi: 10.2337/dc21-S006
Liu AY, Silvestre MP, Poppitt SD. Prevention of type 2 diabetes through lifestyle modification: Is there a role for higher-protein diets? Adv Nutr. 2015; 6: 665-673. doi: 10.3945/an.115.008821
Nebeck K, Gelaye B, Lemma S, Berhane Y, Bekele T, Khali A, 4 Hossain MS et al et al. Hematological parameters and metabolic syndrome: Find-ings from an occupational cohort in Ethiopia. Diabetes MetabSyndr. 2012; 6: 22-27. doi: 10.1016/j.dsx.2012.05.009
Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G, Reyes-Romero MA. Obesity and inflammation: Epi-demiology, risk factors, and markers of inflammation. Int J Endo-crinol. 2013; 2013: 678159. doi: 10.1155/2013/678159
Kim JA, Choi YS, Hong JI, Kim SH, Jung HH, Kim SM. As-sociation of metabolic syndrome with white blood cell subtype and red blood cells. Endocr J. 2006; 53: 133-139. doi: 10.1507/ endocrj.53.133
Chen W, Srinivasan SR, Xu J, Berenson GS. Black-white di-vergence in the relation of white blood cell count to metabolic syndrome in preadolescents, adolescents, and young adults: The Bogalusa Heart Study. Diabetes Care. 2010; 33: 2474-2476. doi: 10.2337/dc10-0619
Farhangi MA, Keshavarz S-A, Eshraghian M, Ostadrahimi A, Saboor-Yaraghi A-A. White blood cell count in women: Relation to inflammatory biomarkers, haematological profiles, visceral adi-posity, and other cardiovascular risk factors. J Health Popul Nutr. 2013; 31: 58-64. doi: 10.3329/jhpn.v31i1.14749
Jiang H, Yan WH, Li CJ, Wang AP, Dou JT, Mu YM. Elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly Chinese people. Int J Environ Res Public Health. 2014; 11: 5497-5509. doi: 10.3390/ ijerph110505497
Nathan DM, Turgeon H, Regan S. Relationship between gly-cated haemoglobin levels and mean glucose levels over time. Dia-betologia. 2007; 50: 2239-2244. doi: 10.1007/s00125-007-0803-0
Pisarczyk-Wiza D, Zozulińska-Ziółkiewicz D, Wysocki H, Wierusz-Wysocka B. Increase in glycemia stimulates reactive oxy-gen species (ROS) production by polymorphonclear neutrophils in type 2 diabetic patiens. J Pre-Clin Clin Res. 2011; 5: 22-27.
Liu S, Hempe JM, McCarter RJ, Li S, Fonseca VA. Associa-tion between inflammation and biological variation in hemoglo-bin A1c in US nondiabetic adults. J Clin Endocrinol Metab. 2015; 100(6): 2364-2371. doi: 10.1210/jc.2014-4454
Lee B-C, Lee J. Cellular and molecular players in adipose tis-sue inflammation in the development of obesity-induced insulin resistance. Biochimica et Biophysica Acta. 2014; 1842: 446-462. doi: 10.1016/j.bbadis.2013.05.017
Gokulakrishnan K, Deepa R, Sampathkumar R, Balasubra-manyam M, Mohan V. Association of leukocyte count with vary-ing degrees of glucose intolerance in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-26). Metab Syndr Relat Disord. 2009; 7: 205-210. doi: 10.1089/met.2008.0024
Goldfine AB, Shoelson SE. Therapeutic approaches target-ing inflammation for diabetes and associated cardiovascular risk. J Clin Investig. 2017; 127(1): 83-93. doi: 10.1172/JCI88884
Yan PJ, Xu Y, Wan Q, Feng J, Li H, Gao CL, et al. Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 dia-betes mellitus patients: A cross-sectional study. Acta Diabetologica. 2017; 54(12): 1091-1019. doi: 10.1007/s00592-017-1044-4
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018; 17(1): 1-4. doi: 10.1186/s12933-018-0762-4
Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buf-fler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. 2011; 106(11): 1911- 1921. doi: 10.1038/ajg.2011.301
Nicholas J, Charlton J, Dregan A, Gulliford MC. Recent HbA1c values and mortality risk in type 2 diabetes. Population-based case-control study. PLoS One. 2013; 8(7): e68008. doi: 10.1371/journal.pone.0068008
Gerstein HC, Swedberg K, Carlsson J, McMurray JJV, Michel-son EL, Olofsson B, et al. The hemoglobin A1c level as a progres-sive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with heart failure. Arch Int Med. 2008; Submit your article to this journal | https://openventio.org/submit-manuscript/ Hossain MS et al 168: 1699-1704. doi: 10.1001/archinte.168.15.1699
Laiteerapong N, Karter AJ, Moffet HH, Cooper JM, Gib-bons RD, Liu JY, et al. Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The diabetes and ag-ing study. J Diabetes Complicat. 2017; 31(1): 94-100. doi: 10.1016/j. jdiacomp.2016.07.023
Walraven I, Mast MR, Hoekstra T, Jansen AP, van der Hei-jden AA, Rauh SP, et al. Distinct HbA1c trajectories in a type 2 diabetes cohort. Acta Diabetol. 2015; 52: 267-275. doi: 10.1007/ s00592-014-0633-8
Chang HY, Wahlqvist ML, Liu WL, Lee MS, Shin SJ, Li YS, et al. Management trajectories in the type 2 diabetes integrated deliv-ery system project in Taiwan: Accounting for behavioral therapy, nutrition education and therapeutics. Asia Pac J Clin Nutr. 2014; 23: 592-606. doi: 10.6133/apjcn.2014.23.4.06
Gebregziabher M, Egede LE, Lynch CP, Echols C, Zhao Y. Effect of trajectories of glycemic control on mortality in type 2 diabetes: A semiparametric joint modeling approach. Am J Epide-miol. 2010; 171: 1090-1098. doi: 10.1093/aje/kwq070
Nichols GA, Joshua-Gotlib S, Parasuraman S. Glycemic con-trol and risk of cardiovascular disease hospitalization and all-cause mortality. J Am Coll Cardiol. 2013; 62: 121-127. doi: 10.1016/j. jacc.2013.04.031
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
